C-reactive protein and serum amyloid A levels in discriminating malignant from non-malignant pleural effusion

Introduction: Distinction between malignant and non-malignant pleural effusion is of great importance in the patient management. The aim: We examined the diagnostic value of C-reactive protein (CRP) and serum amyloid A (SAA) in distinguishing different etiologies of pleural effusion and if they coul...

Full description

Bibliographic Details
Main Authors: Hala Mohamed Shalaby Samaha, Amany Ragab Elsaid, Rasha Elzehery, Rania Elhelaly
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2015-10-01
Series:Egyptian Journal of Chest Disease and Tuberculosis
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0422763815300170
id doaj-9dba766d4caf43c8bfb0da668f8f96c4
record_format Article
spelling doaj-9dba766d4caf43c8bfb0da668f8f96c42020-11-25T00:50:25ZengWolters Kluwer Medknow PublicationsEgyptian Journal of Chest Disease and Tuberculosis0422-76382015-10-0164488789210.1016/j.ejcdt.2015.04.004C-reactive protein and serum amyloid A levels in discriminating malignant from non-malignant pleural effusionHala Mohamed Shalaby Samaha0Amany Ragab Elsaid1Rasha Elzehery2Rania Elhelaly3Chest Disease Department, Faculty of Medicine, Mansoura University, EgyptChest Disease Department, Faculty of Medicine, Mansoura University, EgyptClinical Pathology Department, Faculty of Medicine, Mansoura University, EgyptClinical Pathology Department, Faculty of Medicine, Mansoura University, EgyptIntroduction: Distinction between malignant and non-malignant pleural effusion is of great importance in the patient management. The aim: We examined the diagnostic value of C-reactive protein (CRP) and serum amyloid A (SAA) in distinguishing different etiologies of pleural effusion and if they could discriminate between malignant and non-malignant pleural effusions. Subject and methods: CRP and SAA levels in both serum and pleural fluid were measured in 92 patients with pleural effusion. Of the 92 patients included in our study; 44 were diagnosed with malignant pleural effusions (group I) [with male to female ratio (M/F) 23/21 and mean age 57.7 ± 11.5 years in the form of mean ± 2SD] and 48 were diagnosed with non-malignant pleural effusion (group II) [with M/F ratio 33/15 and mean age 54.7 ± 10.4 years in the form of mean ± 2SD]. Results: CRP and SAA values were significantly higher in both serum and pleural effusion of malignant vs. non-malignant group (P < 0.003), but there was no statistical significant difference as regards pleural/serum CRP and pleural/serum SAA ratios between the two groups (P = 0.148 and P = 0.453 respectively). A statistically significant positive correlation between pleural fluid CRP and pleural fluid SAA in malignant and non-malignant effusions was detected (r = 0.315 and P = 0.002 respectively). Diagnostic performance of pleural fluid CRP and pleural fluid SAA in both infectious and malignant pleural effusions showed that at a cutoff value of 96.15 μg/ml for CRP; diagnostic sensitivity was 61% and specificity was 45%, while for pleural fluid SAA, a cutoff value of 137.5 μg/ml was associated with 41% sensitivity and 93% specificity. Conclusion: Measurement of SAA and CRP levels in pleural fluid has good diagnostic utility in differentiation between malignant and non-malignant pleural effusion and pleural SAA has a better diagnostic performance than CRP.http://www.sciencedirect.com/science/article/pii/S0422763815300170Pleural effusionC-reactive proteinSerum amyloid AMalignantNon-malignant
collection DOAJ
language English
format Article
sources DOAJ
author Hala Mohamed Shalaby Samaha
Amany Ragab Elsaid
Rasha Elzehery
Rania Elhelaly
spellingShingle Hala Mohamed Shalaby Samaha
Amany Ragab Elsaid
Rasha Elzehery
Rania Elhelaly
C-reactive protein and serum amyloid A levels in discriminating malignant from non-malignant pleural effusion
Egyptian Journal of Chest Disease and Tuberculosis
Pleural effusion
C-reactive protein
Serum amyloid A
Malignant
Non-malignant
author_facet Hala Mohamed Shalaby Samaha
Amany Ragab Elsaid
Rasha Elzehery
Rania Elhelaly
author_sort Hala Mohamed Shalaby Samaha
title C-reactive protein and serum amyloid A levels in discriminating malignant from non-malignant pleural effusion
title_short C-reactive protein and serum amyloid A levels in discriminating malignant from non-malignant pleural effusion
title_full C-reactive protein and serum amyloid A levels in discriminating malignant from non-malignant pleural effusion
title_fullStr C-reactive protein and serum amyloid A levels in discriminating malignant from non-malignant pleural effusion
title_full_unstemmed C-reactive protein and serum amyloid A levels in discriminating malignant from non-malignant pleural effusion
title_sort c-reactive protein and serum amyloid a levels in discriminating malignant from non-malignant pleural effusion
publisher Wolters Kluwer Medknow Publications
series Egyptian Journal of Chest Disease and Tuberculosis
issn 0422-7638
publishDate 2015-10-01
description Introduction: Distinction between malignant and non-malignant pleural effusion is of great importance in the patient management. The aim: We examined the diagnostic value of C-reactive protein (CRP) and serum amyloid A (SAA) in distinguishing different etiologies of pleural effusion and if they could discriminate between malignant and non-malignant pleural effusions. Subject and methods: CRP and SAA levels in both serum and pleural fluid were measured in 92 patients with pleural effusion. Of the 92 patients included in our study; 44 were diagnosed with malignant pleural effusions (group I) [with male to female ratio (M/F) 23/21 and mean age 57.7 ± 11.5 years in the form of mean ± 2SD] and 48 were diagnosed with non-malignant pleural effusion (group II) [with M/F ratio 33/15 and mean age 54.7 ± 10.4 years in the form of mean ± 2SD]. Results: CRP and SAA values were significantly higher in both serum and pleural effusion of malignant vs. non-malignant group (P < 0.003), but there was no statistical significant difference as regards pleural/serum CRP and pleural/serum SAA ratios between the two groups (P = 0.148 and P = 0.453 respectively). A statistically significant positive correlation between pleural fluid CRP and pleural fluid SAA in malignant and non-malignant effusions was detected (r = 0.315 and P = 0.002 respectively). Diagnostic performance of pleural fluid CRP and pleural fluid SAA in both infectious and malignant pleural effusions showed that at a cutoff value of 96.15 μg/ml for CRP; diagnostic sensitivity was 61% and specificity was 45%, while for pleural fluid SAA, a cutoff value of 137.5 μg/ml was associated with 41% sensitivity and 93% specificity. Conclusion: Measurement of SAA and CRP levels in pleural fluid has good diagnostic utility in differentiation between malignant and non-malignant pleural effusion and pleural SAA has a better diagnostic performance than CRP.
topic Pleural effusion
C-reactive protein
Serum amyloid A
Malignant
Non-malignant
url http://www.sciencedirect.com/science/article/pii/S0422763815300170
work_keys_str_mv AT halamohamedshalabysamaha creactiveproteinandserumamyloidalevelsindiscriminatingmalignantfromnonmalignantpleuraleffusion
AT amanyragabelsaid creactiveproteinandserumamyloidalevelsindiscriminatingmalignantfromnonmalignantpleuraleffusion
AT rashaelzehery creactiveproteinandserumamyloidalevelsindiscriminatingmalignantfromnonmalignantpleuraleffusion
AT raniaelhelaly creactiveproteinandserumamyloidalevelsindiscriminatingmalignantfromnonmalignantpleuraleffusion
_version_ 1725248247121838080